Analyst Activity – Citigroup Lowers Its Price Target On NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA) to

ME Staff
-
0

Analyst Ratings For NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA)

Today, Citigroup lowered its price target on NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA) to per share.

Some recent analyst ratings include

  • 5/8/2018-Canaccord Genuity Reiterated Rating of Buy.
  • 4/10/2018-JPMorgan Chase & Co. initiated coverage with a Overweight ➝ Overweight rating.
  • 4/6/2018-William Blair Reiterated Rating of Buy.
  • 3/15/2018-Guggenheim initiated coverage with a Neutral ➝ Neutral rating.
  • 2/28/2018-JMP Securities was Downgraded by analysts at JMP Securities from a “Outperform ➝ Market Perform” rating to a “” rating.

Recent Insider Trading Activity For NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA)
NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 10.60% and institutional ownership of 98.37%.

  • On 6/6/2018 Isaac E Ciechanover, CEO, sold 8,800 with an average share price of $48.56 per share and the total transaction amounting to $427,328.00.
  • On 5/22/2018 Isaac E Ciechanover, CEO, sold 8,800 with an average share price of $51.74 per share and the total transaction amounting to $455,312.00.
  • On 5/18/2018 Mitchall G Clark, EVP, sold 25,860 with an average share price of $50.03 per share and the total transaction amounting to $1,293,775.80.
  • On 5/16/2018 Carol Giltner Gallagher, Director, sold 273 with an average share price of $46.06 per share and the total transaction amounting to $12,574.38.
  • On 5/16/2018 Mitchall G Clark, EVP, sold 4,647 with an average share price of $46.06 per share and the total transaction amounting to $214,040.82.
  • On 5/15/2018 Derrell Porter, SVP, sold 16,334 with an average share price of $45.02 per share and the total transaction amounting to $735,356.68.
  • On 5/14/2018 Matthew K Fust, Director, sold 12,286 with an average share price of $43.57 per share and the total transaction amounting to $535,301.02.

Recent Trading Activity for NASDAQ:ATRA – Atara Biotherapeutics (NASDAQ:ATRA)
Shares of NASDAQ:ATRA – Atara Biotherapeutics closed the previous trading session at 42.90 down -2.10 4.67% with 44.79999923706055 shares trading hands.